Cryosurgery for diverse neoplastic and non-neoplastic diseases has expanded in applicability in recent years, especially since intraoperative ultrasound became available as a method of monitoring the process of tissue freezing. However, persistence of disease after presumably adequate cryosurgical treatment has disclosed deficiencies in the technique, perhaps due to faulty application of the freeze-thaw cycles or due to shortcomings in the imaging method. Clearly cryosurgical technique is less than optimal.
Introduction

Progress Toward Optimization of Cryosurgery
Some facets of cryosurgical technique are optimal for effective therapy, whether intended for cure of non-neoplastic or neoplastic disease. Good results are being achieved in such widely diverse clinical problems as cardiac tachyarrythmias and cancers of many tissues and organs. On the other hand, especially in the treatment of neoplastic disease, cryosurgical techniques are less than optimal. For example, the incidence of persistent cancer in the cryosurgically treated site in liver and prostate cancer is in the range of 10-40% (1-4), a rate which depends in part on selection criteria by the physician. However, this rate of failure also is an indication that the cryosurgical treatment was less than optimal and is in need of improvement.
The reasons for persistent disease in the cryosurgically treated lesion are several. Perhaps an error in evaluation of the extent of disease was made, possibly in interpretation of the image provided by ultrasound, computerized tomography or magnetic resonance. Perhaps the technique of cryoablation was not optimal because of insufficient freezing or difficulty in monitoring the freezing by whatever method was in use. Any of these factors could result in an unsatisfactory long-term result in terms of survival or freedom from disease. Of course, even if the technique is perfect, biological tissues resist freezing injury. Cryosurgery has its limitations, so the direction of research must be toward the resolution of a number of factors affecting its efficacy.
By dosimetry, we mean the tissue-type and temperature need in treatment, that is, the exposure of the tumor to lethal freezing temperatures for an appropriate duration. By imaging, we mean the continued development of techniques to detect the extent of disease and monitor more accurately the process of freezing of tissue. By adjunctive therapy, we mean the use of other therapeutic approaches in combination to assist the freezing temperature in the destruction of cells, especially in the border zone of the cryogenic lesion.
Dosimetry
Ever since the beginning of the modern era of cryosurgery, which was initiated with the development of automated apparatus by Cooper and Lee in the 1960's, many efforts have been made to describe an "ablative dose" of freezing. Initially the supposition was made that the localized, sharply demarcated zone of the frozen tissue was considered lethal, especially when a second freeze-thaw cycle was included within the cryosurgical procedure. However that concept did not prevail very long. Early in modern cryosurgical experience, it was commonly thought that a temperature of -20º C was destructive to cells and was a desirable temperature to be achieved in treatment. This thought was influenced by work with frostbite, such as that of Kreyberg, who stated that consistent tissue damage was seen at temperatures between -10 and -20º C (5). In the mid 1960's, Cooper wrote that "…all living tissue subjected to a temperature of -20º C or below for 1 minute or longer will undergo cryogenic congelation and necrosis." (6). No detail is given about the method of determining the duration of freezing.
As cryosurgery came into use for the treatment of cancers, the need for tissue temperatures lower (colder) than -20º C quickly became evident. In 1971, Neel and colleagues, utilizing a mouse tumor model, found that effective tumor control required rapid repeated freezing to tissue temperatures below -60º C (7). Similar conclusions were reached by Gage in canine experiments and clinical trials. Cryosurgery for human tumors demonstrated the need to achieve that temperature range, which compelled the placement of needle thermocouples in appropriate sites to be certain that the targeted lethal temperature was achieved in the tissues (8, 9) . None of the early reports addressed the issue of time-at-temperature. Instead the duration of freezing was determined by whatever time was required to freeze the tumor to a tissue temperature of about -50º C at the periphery of the lesion.
The basic question of how long the "frozen tissue" should be held in the frozen state at a destructive temperature was asked early in cryosurgery, as Mazur counseled that time at a given temperature was important (10). Later cryosurgical experimentation on canine skin and palate showed a greater destructive effect from prolongation of freezing (11, 12) .
Other investigations also demonstrated that when frozen cells or tissues are held in the range of -20 to -40º C, damage is increased (13) (14) (15) (16) . Holding the tissue in the frozen state at temperatures warmer than -40º C will increase destruction because time is provided for solute effects, extended intracellular ice formation and possibly recrystallization. In clinical practice, the evidence suggests that tissue should be held in the frozen state at a selected temperature for several minutes. The exact duration remains uncertain and may be cell/tissue-type specific. For the same reasons, that is, allowing time for solute effects, intracellular ice formation, and recrystallization, the thawing rate should be slow.
More recently, -40º C has emerged as the target temperature based on a variety of in vitro and animal studies and the physics of pure water, which suggests that small volumes ("cell sized") of liquid water do not have the ability to undercool (remain a liquid) much below -40º C. Accordingly, freezable liquid water in a cell would be expected to crystallize near -40º C resulting in the spread of lethal intracellular ice. Taken together, our knowledge of the physics of water, our nascent understanding of the biology of cells at low temperatures and the conclusions drawn from preclinical experimentation, we teach that -40º C for "a few minutes" represents a targeted "lethal dose".
We further accept the limited precision of targeted tissue freezing by considering the secondary destructive effects that occur following thawing. Shortly after thawing, a necrotic cascade is launched culminating in a pathologically defined state, "coagulative necrosis". This state exists due primarily to the damaged endothelial cell lining of the microvascular supplying the "frozen tissue" with resulting edema and inflammation. Accordingly, we are cognizant of the additive, deleterious effects of the freezing process, the solution effects attendant to the freezing process and role played by post-thaw vascular stasis.
Dosimetry implies a discrete time-energy relationship. The challenge of precise "dosing" with cryosurgery is found in the discontinuity in temperature (the thermal gradient measured across the "ice ball"), the time of exposure within a given isothermal boundary, the frequency of exposure (variations in the freeze-thaw cycle), and the differential rates of cooling and thawing across the geometry of the "ice ball". As a cryoprobe or cluster of probes is activated (the heat sink), heat is extracted from the targeted tissue at a rapid rate close to the probe and at reduced rates distant from the probe surface. Accordingly, any given cell within the targeted zone will experience distinct cooling and thawing rates, varying exposure temperatures and shortening times of exposure to a given temperature with distance from the probe. Added to the dosing challenge is the inherent biological variables found within the tissue target. First, the vascular supply can vary within tissues as can the vasoconstrictive response of the arterioles supplying blood to the tissue. As chilling progresses, reflex vasodilatory responses may cause thermal discontinuities yielding undertreated foci. This effect is most pronounced at the "ice ball" periphery and with widespread probe placement. Second, cellular responses to a low temperature insult can vary with cell type (neoplastic vs. normal) and with reproductive stage of a given cell type (cell cycle). These response differentials are poorly understood and lead us to suggest that cryotherapeutic dosimetry will require uniformly ablative conditions. We also know that the full extent of the deleterious effects may not manifest for hours, days, and even weeks post-thaw. Molecular-based cellular events (i.e., apoptosis) have recently been implicated as contributing to the cascade of cell death related events. These events may augment therapeutic effectiveness of a cryosurgical procedure especially at and near the freeze zone periphery. Good cryosurgical technique designed to yield complete destruction of the cancer must take advantage of the full spectrum cell death dependent inductive factors. Therefore, knowledge of the interplay between these factors and their additive effects is necessary to support progressive improvement in surgical outcomes. Ideally, an optimized cryosurgical procedure would be one in which the thermal variables are sufficiently controlled so as to provide uniformity across the targeted tissues. This almost certainly is an impossible goal. The optimal cryosurgical technique, at least for tumors, will remain freezing the tumor and an adjacent appropriate margin of normal tissue to the range of -40 to -50º C, hold that temperature for several minutes, thaw slowly and repeat the freeze-thaw cycle (17). Therefore, if the technique was used in reported cases, one must look elsewhere if the efficacy of cryosurgery is to be increased.
Monitoring By Image
Monitoring the cryosurgical procedure by the measurement of tissue temperature with thermocouples was adopted as an essential part of the technique early in modern cryosurgery. Even though multiple thermocouples were often used, each thermocouple provided only a single-point measurement. Furthermore, thermocouple use was not practical in all locations. In the 1990's, intraoperative ultrasound came into use as a monitor of the cryosurgical procedure. This imaging technique provided a more global view and a real time image of the frozen volume of tissue. However, the shortcomings of the technique were soon recognized. Complete posterior acoustic shadowing obscured the depth of freezing, so a three dimensional image was not obtained (18) (19) (20) . Some compensation for this limitation was accomplished by viewing the frozen volume from several angles on three-dimensional ultrasound (21, 22) . Its use has been thought to improve the accuracy of placement of ablative devices in the treatment of liver tumors (23). Another limitation of ultrasound is the fact that the image provides no information about tissue temperature, which cannot be judged accurately from the image (24). The critical -40º C isotherm is well within the periphery of the frozen volume. The use of thermocouples in conjunction with ultrasound adds an increased level of certainty to the success of prostatic cryosurgery (25).
New directions in imaging for cryosurgery include computerized tomography (CT), magnetic resonance imaging (MRI), and electrical impedance tomography (EIT). CT shows the entire cross sectional image of the frozen tissue. The images are made at intervals of a minute or two, which is not real time but still within the realm of usefulness (26). The related cost of use will be a factor.
MRI, which provides a three dimensional view of the volume of frozen tissue, shows promise as a clinically valuable technique (27) (28) (29) (30) (31) . MRI-compatible cryoprobes, made of non-ferromagnetic materials, are required. The temperature within the frozen volume can be quantified by the use of mathematical models (32-34). The excellent report of Mala and his associates (35) used a bioheat equation to evaluate the thermal isotherms during MRI imaging. Creating frozen lesions in the liver of pigs, the isotherms were determined. The -40º C isotherm enclosed 26% of the frozen volume, which demonstrates the need to expand the border of freezing to a considerable distance beyond a neoplastic lesion. In a later report, Mala and associates (36) , using MRI in patients with liver tumors, noted that excellent visualization of the frozen volume was provided. The volume of frozen tissue was increased by about 42% by a second freeze cycle. The techniques with MRI are still evolving, including in the direction of improved image contrast (37). However, the probability of extensive or routine clinical use in the near future is remote because of the expense of the equipment and special needs related to the electromagnetic field.
Electrical impedance tomography (EIT) has been proposed as a method to provide real time imaging. During the freezing of tissue, ice crystals form, initially in the extracellular spaces. About 99% of extracellular water is frozen when the temperature reaches -15º C. Then the electrical impedance in the frozen tissue rises from the level of several kilohms to several megaohms. Local impedancemetry, which used electrodes placed in the tissue to be frozen, was described for use in cryosurgery by Le Pivert and associates in 1977 (38) . Like thermocouples, the impedance technique did not provide a global view. EIT provides a global image by introducing low amplitude AC currents into the body, thus measuring the electrical potentials on the body surface. These potentials are then analyzed to create a tomographic image (39, 40) . This approach to imaging needs further development and testing for use in cryosurgery.
Adjunctive Therapy
The frozen volume of tissue is subjected to varying temperatures and other variable features of the freeze-thaw cycle. The tissue at the periphery of the frozen volume, exposed to warmer freezing temperatures for a longer duration as well as thawing more quickly, contains partially damaged cells and devitalized cells. Also in this region, based primarily on in vitro data, are cells in an apoptotic state. Only recently has cryosurgery been associated with apoptosis (41, 42) . Several investigations have suggested that pharmacologic agents may be used to enhance apoptosis and influence the efficacy of cryosurgery (43-45). To increase the chance of cure, adjunctive therapy is needed to increase the rate and completeness of cell death in the periphery of the cryogenic lesion. Adjunctive therapy may consist of anticancer drugs, irradiation, or other agents.
Cancer chemotherapeutic drugs are the most commonly used adjunctive therapeutic agents. Cancer chemotherapy has been used in patients who also have cryosurgical treatment for many years, that is, since the diverse clinical uses of cryosurgery for cancers in the late 1960's and 1970's. However, in those years no effort was made to integrate the drugs into the cryosurgical therapy in an orderly manner.
The possibility that cancer chemotherapeutic drugs can be concentrated in the tumor area by appropriately timed delivery, as suggested by Benson (47) , led the way to future research directed at synergistic use of such agents with cryosurgery. If drugs are administered during cryosurgery, as microcirculatory failure occurs just after thawing of the tissue, the therapeutic agents will become sequestered or trapped in the tumor. Ikekawa et al. (48) administered the drug just after thawing and showed that this sequestration happens in a murine tumor model, resulting in a high longlasting concentration in the tumor. Homasson et al. (49) also have demonstrated this localization of drug when bleomycin was given in the therapy of lung cancer. Drugs can be injected directly into tumors in the period of thawing without significant entry into the general circulation.
The common use of drugs is via the systemic route. Cooper and Fraser (50) , in animal experiments with cryosurgery suggested that the use of cyclophosphamide potentiated cell-mediated immunity. However, it is more likely that the anti-cancer drugs are helpful by way of prompting apoptosis, as suggested by the experiments of Clarke et al. (44) which showed that a combination of freezing and 5-fluouracil produced a greater reduction in cell survival than either freezing or the drug alone. Another mechanism of benefit was suggested by Mir and Rubinsky (51) who, freezing melanoma cells in vitro, found that the cells became permeable to bleomycin. This drug does ordi-narily not permeate cells, so these experiments have therapeutic implications. The clinical use of drugs as an adjunct to cryosurgery is common and is considered beneficial (52). The optimal dose and timing of delivery is not well defined. A measure of caution is needed, especially when used as an adjunct to cryosurgery of hepatic tumors in which the combined effect may lead to coagulopathy in freezing large volumes of tissue (53, 54) .
Radiotherapy is commonly used in the course of many tumors treated also by cryosurgery. However, as an adjunctive agent, the timing of delivery of irradiation is not clear. Experiments in vitro have shown that the radiosensitivity of cooled cells is increased (55, 56). One would expect that radiotherapy and cryosurgery, synchronized in some manner, would add to the efficacy of both, but that investigation has not yet been done.
Other methods of adjunctive therapy, including antifreeze proteins and apoptosis, have been proposed but are untested clinically as yet. Koushafar and Rubinsky (57) have shown that the destructive effects of freezing are enhanced by antifreeze proteins, which are glycoproteins that can affect the formation of ice crystals. The intracellular ice crystals, which form at warm freezing temperatures, cause mechanical damage to the cells. Experiments in vivo, injecting the antifreeze protein into the tumor before freezing, have produced enhanced tissue destruction (58, 59) . Apoptosis promoting drugs, used in cell suspensions, have increased the damage from freezing injury (41). The clinical potential of these agents require further investigation.
As adjunctive therapeutic agents, the role of immunological enhancers must be considered. The concept of cryoimmunology, that is, that freezing cancer tissue in situ will elicit a beneficial immunological response, was proposed by Shulman et al. in 1967 (60) . Since then, many investigations have been directed at the nature of the immunologic response. Benefit on an immunological basis has been shown after cryosurgery of tumors in animals (61-63). Some investigations, such as that of Hoffman and his associates (64) found no evidence of benefit in a prostatic cancer cell line in animals. Immunological-enhancing drugs have been used to stimulate the immune response and have been considered experimentally and clinically helpful (65-67). Nevertheless, clear evidence of benefit in human tumors is lacking.
On the other hand, like the Roman God Janus, cryoimmunology has another face, one which may have a harmful effect.
In animal experiments, cryosurgery has been found to provoke enhanced metastases (68). In animals and in humans, deleterious inflammatory responses in organs, called cryoshock in some reports, are apparently due to cytokine release (54, (69) (70) (71) (72) . In humans, this is more likely to follow the freezing of large volumes of tissue (73, 74) . Considering all aspects of the subject, interest in cryoimmunology is quite high and still has some potential future application (75).
Summary
Cryosurgery for tumors continues to have a place in the therapeutic armamentarium for neoplasms. The percutaneous and laparoscopic approaches to cryosurgery are extending the usefulness of freezing ablative procedures. Nevertheless, optimal application of cryosurgical techniques is limited in some anatomic locations, such as the proximity of the prostate gland to the rectum, and limited by the need to produce a greater certainty of destruction in a larger volume of the frozen tissue. These limitations emphasize the importance of adjunctive therapy in some form.
To ensure further progress, the directions for research should include greater depth of inquiry into the mechanisms of injury and healing response of frozen cells and tissues, and continued improvement in the imaging techniques. A definition of the appropriate adjunctive therapy for each type of neoplasm is sorely needed.
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